EZANZA ApS
CVR: 29686785
The financial health of EZANZA ApS shows signs of volatility, with a notable decline in profitability in 2025, reporting a loss of 129,697 DKK despite an increase in revenue to 8,047,532 DKK. Revenue has generally trended upward from 3,133,848 DKK in 2021 to 8,047,532 DKK in 2025, indicating growth in sales; however, profit margins have fluctuated significantly, with a peak profit of 121,686 DKK in 2023 followed by losses in subsequent years. The company's equity has decreased from 353,426 DKK in 2023 to 215,458 DKK in 2025, raising concerns about its financial stability. Operating in the traditional, complementary, and alternative treatment sector, EZANZA ApS is positioned for growth but must address its profitability challenges to strengthen its market position.
AI-generated summary
Overview
Details
Contact
Advertising protectedPurpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 8 mio. | -130 t. | 976 t. | 215 t. | - | |
History
Ownership
Management
Directors
Founders
Production units (3)
Similar companies
Companies in the same industry and area